# Meijie Wang

> Meijie Wang is the co-founder and CEO of MetaNovas, an AI-driven biotech that designs functional peptides for skincare, supplements and drug discovery. A former NVIDIA AI infrastructure engineer who built VR games and worked on AI at Stanford's School of Medicine, he now runs a Silicon Valley and Shanghai operation whose knowledge-graph platform aims to compress the decade-long hunt for new bioactive ingredients into something far shorter. MetaNovas counts L'Oreal, Beiersdorf, Haleon, Takeda and Unilever among its partners and raised a Series A led by GL Ventures.

- **Role:** Co-Founder & CEO at MetaNovas
- **Organizations:** MetaNovas Biotech, MetaNovas AI
- **Nationality:** Chinese
- **Education:** Bachelor's, Cross-disciplinary Pilot Class, Tongji University, MS, Computer Software and Media Applications, Worcester Polytechnic Institute, Technology and Engineering Management, Stanford University
- **Known for:** Co-founded and leads MetaNovas, an AI biotech operating across Silicon Valley and Shanghai, Won L'Oreal Big Bang 2023 Beauty Technology Challenge, Built strategic partnerships with L'Oreal, Beiersdorf, Haleon, Takeda and Unilever

## Career timeline

- **2015** — Co-founded Studio Qfun, a VR and gaming studio
- **2018** — Co-founded Nod App
- **2019** — R&D Software Engineer at Olympus Corporation of the Americas
- **2020** — AI Infrastructure Software Engineer at NVIDIA
- **2021** — Research Engineer for AI Applications (DawnLight / Stanford School of Medicine)
- **2021** — Co-founded MetaNovas Biotech with Lun Yu; became CEO
- **2022** — MetaNovas secures roughly $10M in funding
- **2023** — Won L'Oreal Big Bang Beauty Tech Challenge; presented at IFSCC Congress
- **2024** — MetaNovas completes Series A led by GL Ventures and Baoding Venture Capital

## Achievements

- Co-founded and leads MetaNovas, an AI biotech operating across Silicon Valley and Shanghai
- Won L'Oreal Big Bang 2023 Beauty Technology Challenge
- Built strategic partnerships with L'Oreal, Beiersdorf, Haleon, Takeda and Unilever
- MetaNovas holds 10+ patents across the US and China
- Research published in Nature sub-journals; presented at IFSCC, MIT ILP and SCC
- Named among 250 Most Promising Early-stage Digital Health Ventures
- Former NVIDIA AI infrastructure engineer and Arctic Code Vault contributor

## Latest updates

- **2024-12** — MetaNovas completed a Series A round led by GL Ventures and Baoding Venture Capital, with Ruoyuchen co-investing.
- **2024** — Detailed its AI-designed acne-targeting peptide MetaAMP33, built on the MetaPep platform.

## Links

- Website: https://metanovas.com
- LinkedIn: http://www.linkedin.com/in/meijie-wang
- GitHub: https://github.com/wmjpillow

---

Profile page: https://yespress.io/meijie-wang
Published by YesPress — https://yespress.io
Last updated: 2026-06-10